(PharmaNewsWire.Com, March 10, 2017 ) According to the report Europe Cardiac Assist Device Market, published by Market Data Forecast, the European market was worth $396.6 million in 2015 and is projected to reach $602.4 million with CAGR of 8.72% by 2020.
Cardiac assist devices are designed to assist or replace the natural heart. These devices can be used as short‐term therapy, bridge to transplantation, and as permanent cardiac support. One of the leading causes of death in European countries is heart failure, which raise an urgent demand for these devices in this region.
To meet the increasing demand for cardiac therapies in the European countries, the Cardiac Assist Devices are used in patients suffering from End-Stage Congestive Heart Failure, where the chances of survival through medications alone are minimal. As new novel technologically, advanced products are being introduces this will further upsurge demand for cardiac assist devices in the near future.
Existence of alternative treatment like pacemaker, heart transplantation and etc. and the associated compatibility issues with the device implantation, such as respiratory failure, development of blood clots and device failure restrain the market growth. Increased government expenditure on healthcare and availability of more efficient and minimally invasive devices in future are driving the cardiac assist devices market.
Segmentation • By Type • Ventricular Assist Device. • Right Ventricular Assist Device. • Left Ventricular Assist Device. • Bi-Ventricular Assist Device. • External Ventricular Assist Devices. • Intra-Aortic Balloon Pump. • Total Artificial Pump • By Geography
Thoratec Corporation, MAQUET GmbH & Co, Teleflex Incorporated, Berlin Heart GmbH, Abiomed, Inc., HeartWare International, SynCardia Systems, Inc. are the leading market players with dominance over 60% of the market. Thoratec Corporation and Berlin Heart are the prominent players in the VAD segment whereas Teleflex and MAQUET are dominant players in the Intra-Aortic Balloon Pumps (IABP) segment. SynCardia is the foremost company to provide the only Food and Drug Administration (FDA) approved Total Artificial Heart (TAH).
Some other potential players in the market include Jarvik Heart, Inc. and Terumo Corporation. Braile Biomedica Ltd., CardiacAssist, Inc., CardioBridge GmbH, Carmat SAS, Cleveland Heart, Inc., CorAssist Cardiovascular Ltd., Evaheart Medical USA, Inc., Leviticus Cardio Ltd., MyoCardioCare, Inc.
The European Cardiac Assist Devices Market study offers following deliverables: • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions those are still untapped. • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics. • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis. • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development. • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment. • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies. • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions. • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
Checkout other related studies in the Medical Devices Segment:
About us Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
